摘要
雌激素受体(ER)介导了许多涉及血管炎症和粥样硬化过程中细胞和分子的有利效应。然而,也存在不利效应。实际上,绝经前女性与绝经后女性或同龄男性相比,患心血管疾病的风险显著降低,而绝经后女性与同龄绝经前女性相比心血管疾病发病率更高。ER受体亚型表达之间的平衡可能在雌激素矛盾特征(有利和有害效应)中起着重要作用。新发现的激活型雌激素受体GPR30,显示出可作为冠心病治疗靶点的潜力,但仍未清楚阐明介导GPR30功能的信号机制。本文诣在总结每个雌激素受体亚型作用的知识现状,这些受体在动脉粥样硬化炎症过程中介导不同细胞成分的直接雌激素活动。我们希望这些知识能为解释雌激素既有利又有害的矛盾特征带来曙光,并推进效益/风险比提高的特效ER激动剂和拮抗剂的研发。
关键词: 动脉粥样硬化,内皮细胞,雌激素受体α,雌激素受体β,GPR-30,血管炎症,血管平滑肌细胞。
Current Medicinal Chemistry
Title:Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors
Volume: 22 Issue: 22
Author(s): Eva Kassi, Eliana Spilioti, Narjes Nasiri-Ansari, Christos Adamopoulos, Paraskevi Moutsatsou, Aggeliki Papapanagiotou, Gerasimos Siasos, Dimitris Tousoulis and Athanasios G. Papavassiliou
Affiliation:
关键词: 动脉粥样硬化,内皮细胞,雌激素受体α,雌激素受体β,GPR-30,血管炎症,血管平滑肌细胞。
摘要: Estrogen receptors mediate numerous favorable effects on cells and molecules implicated in vascular inflammation and atherogenic process. However, harmful effects have also been suggested. Actually, premenopausal women have a significantly lower risk for cardiovascular disease compared to postmenopausal women or age matched males while the incidence of cardiovascular disease is greater in postmenopausal than premenopausal women of the same age. The balance between the expression of ER subtypes may play an important role in the paradoxical characterization of estrogens as both beneficial and harmful. The activation of the newly discovered estrogen receptor GPR30 appears to be of great potential as therapeutic target in coronary heart disease, though the signaling mechanisms mediated GPR30 function still have not fully elucidated. The aim of this review is to summarize the current state of knowledge on the role of each estrogen receptor subtype in mediating the direct estrogen actions on different cellular components that participate in the atherosclerotic inflammatory process. We hope this knowledge will shed some light on the cause of the paradoxical characterization of estrogens as both beneficial and harmful, and advance the research in the development of specific ERagonists/ antagonists with improved benefit/risk ratio.
Export Options
About this article
Cite this article as:
Eva Kassi , Eliana Spilioti , Narjes Nasiri-Ansari , Christos Adamopoulos , Paraskevi Moutsatsou , Aggeliki Papapanagiotou , Gerasimos Siasos , Dimitris Tousoulis and Athanasios G. Papavassiliou , Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors, Current Medicinal Chemistry 2015; 22 (22) . https://dx.doi.org/10.2174/0929867322666150608093607
DOI https://dx.doi.org/10.2174/0929867322666150608093607 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Knowledge and Perceptions Towards Cardiovascular Disease Prevention Among Patients with Type 2 Diabetes Mellitus: A Review of Current Assessments and Recommendations
Current Diabetes Reviews Chemistry and Biology of Indoles and Indazoles: A Mini-Review
Mini-Reviews in Medicinal Chemistry Bio Molecular Considerations in Major Depression and Ischemic Cardiovascular Disease
Central Nervous System Agents in Medicinal Chemistry Sex Differences in Biomarkers for Predicting Cardiovascular and Coronary Events
Current Vascular Pharmacology The Patented Uses of D-Ribose in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Protective Effects of Astragalus Membranaceus and Ligustrazine on Rat Brain Microvascular Endothelial Cell Injury after Oxygen-Glucose Deprivation/ Reoxygenation by Suppressing the PKCδ/MARCKS Pathway
Combinatorial Chemistry & High Throughput Screening Glycoconjugates of Quinolines: Application in Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry Hydroxyimine NO-Donors; FK409 and Derivatives
Current Topics in Medicinal Chemistry New Antimicrobial Approaches: Reuse of Old Drugs
Current Drug Targets Thrombin-Activatable Fibrinolysis Inhibitor
Current Medicinal Chemistry Microalbuminuria In Primary Hypertension
Current Hypertension Reviews Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance
Current Topics in Medicinal Chemistry Pharmacogenetics of Antihypertensive Therapies: Can this be Applied in the Clinic?
Current Pharmacogenomics and Personalized Medicine Nitric Oxide and Dietary Factors: Part IV Traditional Japanese Food (Soy Products, Fish and Tea)
Vascular Disease Prevention (Discontinued) Viral Anti-Inflammatory Reagents: The Potential for Treatment of Arthritic and Vasculitic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets MTHFR Gene Polymorphism and Diabetic Retinopathy
Current Diabetes Reviews Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients
Current Pharmaceutical Biotechnology Neuro-Psychological Pattern in Patients Suffering from Primitive Dilated Cardiomyopathy with Impairment in Executive Function
Current Neurovascular Research Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel
Current Vascular Pharmacology Pulmonary Hypertension secondary to Left Heart Disease
Current Vascular Pharmacology